Phosphoserine Functionalized Cements Preserve Metastable Phases, and Reprecipitate Octacalcium Phosphate, Hydroxyapatite, Dicalcium Phosphate, and Amorphous Calcium Phosphate, during Degradation, In Vitro
Source abstract
Abstract
Phosphoserine modified cements (PMC) exhibit unique properties, including strong adhesion to tissues and biomaterials. While TTCP-PMCs remodel into bone in vivo, little is known regarding the bioactivity and physiochemical changes that occur during resorption. In the present study, changes in the mechanical strength and composition were evaluated for 28 days, for three formulations of αTCP based PMCs. PMCs were significantly stronger than unmodified cement (38–49 MPa vs. 10 MPa). Inclusion of wollastonite in PMCs appeared to accelerate the conversion to hydroxyapatite, coincident with slight decrease in strength. In non-wollastonite PMCs the initial compressive strength did not change after 28 days in PBS (p > 0.99). Dissolution/degradation of PMC was evaluated in acidic (pH 2.7, pH 4.0), and supersaturated fluids (simulated body fluid (SBF)). PMCs exhibited comparable mass loss (<15%) after 14 days, regardless of pH and ionic concentration. Electron microscopy, infrared spectroscopy, and X-ray analysis revealed that significant amounts of brushite, octacalcium phosphate, and hydroxyapatite reprecipitated, following dissolution in acidic conditions (pH 2.7), while amorphous calcium phosphate formed in SBF. In conclusion, PMC surfaces remodel into metastable precursors to hydroxyapatite, in both acidic and neutral environments. By tuning the composition of PMCs, durable strength in fluids, and rapid transformation can be obtained.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Endodontics and Root Canal Treatments · Calcium Carbonate Crystallization and Inhibition
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Applied Material Science, Department of Engineering, Uppsala University, 75121 Uppsala, Sweden
Funding
Stiftelsen för Strategisk Forskning
References (94)
Show source-provided references
1. Luo, J., Faivre, J., Engqvist, H., and Persson, C. (2019). The Addition of Poly(Vinyl Alcohol) Fibers to Apatitic Calcium Phosphate Cement Can Improve Its Toughness. Materials, 12.10.3390/ma12091531 ↗
2. Biological and Medical Significance of Calcium Phosphates10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1 ↗
3. Calcium Orthophosphate (CaPO4) Scaffolds for Bone Tissue Engineering Applications10.14302/issn.2576-6694.jbbs-18-2143 ↗
4. Structure and mechanical properties of selected biological materials10.1016/j.jmbbm.2008.02.003 ↗
5. Advanced Structural Materials by Bioinspiration10.1002/adem.201600787 ↗
6. Interactions Between Inorganic and Organic Phases in Bone Tissue as a Source of Inspiration for Design of Novel Nanocomposites10.1089/ten.teb.2013.0221 ↗
7. Mechanical properties and the hierarchical structure of bone10.1016/S1350-4533(98)00007-1 ↗
8. The Organic−Mineral Interface in Bone Is Predominantly Polysaccharide10.1021/cm702054c ↗
9. The structure and mechanics of bone10.1007/s10853-011-5914-9 ↗
10. Tuning hardness in calcite by incorporation of amino acids10.1038/nmat4631 ↗
11. Control of Biogenic Nanocrystal Formation in Biomineralization10.1002/ijch.201500038 ↗
12. Modification of Calcium Phosphate Cement with α-Hydroxy Acids and Their Salts10.1021/cm048803z ↗
13. Effect of several additives and their admixtures on the physico-chemical properties of a calcium phosphate cement10.1023/A:1008997118576 ↗
14. Improvement of physical properties of calcium phosphate cement by elastin-like polypeptide supplementation10.1038/s41598-018-23577-y ↗
15. Calcium phosphate cements: Action of setting regulators on the properties of the β-tricalcium phosphate-monocalcium phosphate cements10.1016/0142-9612(89)90120-8 ↗
16. Effect of Organic Acids on Calcium Phosphate Nucleation and Osteogenic Differentiation of Human Mesenchymal Stem Cells on Peptide Functionalized Nanofibers10.1021/acs.langmuir.5b00615 ↗
17. Molecular modifiers reveal a mechanism of pathological crystal growth inhibition10.1038/nature19062 ↗
18. Strongly bound citrate stabilizes the apatite nanocrystals in bone10.1073/pnas.1009219107 ↗
19. Mechanisms of Modulation of Calcium Phosphate Pathological Mineralization by Mobile and Immobile Small-Molecule Inhibitors10.1021/acs.jpcb.7b10956 ↗
20. Pastero, L., Bruno, M., and Aquilano, D. (2018). Habit Change of Monoclinic Hydroxyapatite Crystals Growing from Aqueous Solution in the Presence of Citrate Ions: The Role of 2D Epitaxy. Crystals, 8.10.3390/cryst8080308 ↗
21. Influence of polymeric additives on the mechanical properties of α-tricalcium phosphate cement10.1016/S8756-3282(99)00143-X ↗
22. Dual-Crosslinking of Hyaluronic Acid–Calcium Phosphate Nanocomposite Hydrogels for Enhanced Mechanical Properties and Biological Performance10.1002/mame.201700160 ↗
23. Effects of different crosslinking methods on the properties of collagen–calcium phosphate composite materials10.1016/j.ijbiomac.2014.12.023 ↗
24. Perez, R.A., Kim, H.-W., and Ginebra, M.-P. (2012). Polymeric additives to enhance the functional properties of calcium phosphate cements. J. Tissue Eng., 3.10.1177/2041731412439555 ↗
25. Controlling the reactivity of calcium phosphate cements10.1039/b811953h ↗
26. Combining particle size distribution and isothermal calorimetry data to determine the reaction kinetics of α-tricalcium phosphate–water mixtures10.1016/j.actbio.2006.01.003 ↗
27. Unosson, J., and Engqvist, H. (2014). Development of a Resorbable Calcium Phosphate Cement with Load Bearing Capacity. Bioceram. Dev. Appl., 4.
28. Reactivity of calcium phosphate cements10.1039/b706411j ↗
29. Sintering effects on chemical and physical properties of bioactive ceramics10.1007/s40145-013-0072-y ↗
30. Polymeric-Calcium Phosphate Cement Composites-Material Properties: In Vitro and In Vivo Investigations10.1155/2010/691452 ↗
31. Polymer—Calcium phosphate cement composites for bone substitutes10.1002/jbm.10222 ↗
32. Huang, B., Caetano, G., Vyas, C., Blaker, J.J., Diver, C., and Bartolo, P. (2018). Polymer-Ceramic Composite Scaffolds: The Effect of Hydroxyapatite and beta-tri-Calcium Phosphate. Materials, 11.10.3390/ma11010129 ↗
33. Covalently cross-linked hydroxyapatite–citric acid–based biomimetic polymeric composites for bone applications10.1177/0883911515585181 ↗
34. The importance of amino acid interactions in the crystallization of hydroxyapatite10.1098/rsif.2012.0906 ↗
35. Chiral acidic amino acids induce chiral hierarchical structure in calcium carbonate10.1038/ncomms15066 ↗
36. The effect of aminoacids on the crystal growth of calcium carbonate10.1016/S0022-0248(01)02164-9 ↗
37. A potential mechanism for amino acid-controlled crystal growth of hydroxyapatite10.1039/C5TB01036E ↗
38. O-phospho-l-serine: A modulator of bone healing in calcium-phosphate cements10.1515/BMT.2008.040 ↗
39. Phosphoserine—A convenient compound for modification of calcium phosphate bone cement collagen composites10.1023/B:JMSM.0000021119.14870.3d ↗
40. Crystallization of citrate-stabilized amorphous calcium phosphate to nanocrystalline apatite: A surface-mediated transformation10.1039/C6CE00521G ↗
41. Rubini, K., Boanini, E., and Bigi, A. (2019). Role of Aspartic and Polyaspartic Acid on the Synthesis and Hydrolysis of Brushite. J. Funct. Biomater., 10.10.3390/jfb10010011 ↗
42. Stabilization of amorphous calcium carbonate by phosphate rich organic matrix proteins and by single phosphoamino acids10.1016/j.jsb.2010.04.007 ↗
43. Amorphous calcium phosphates: Synthesis, properties and uses in biomaterials10.1016/j.actbio.2010.02.017 ↗
44. Amorphous surface layer versus transient amorphous precursor phase in bone—A case study investigated by solid-state NMR spectroscopy10.1016/j.actbio.2017.06.040 ↗
45. Water-mediated structuring of bone apatite10.1038/nmat3787 ↗
46. Role of Extracellular Vesicles in De Novo Mineralization10.1161/ATVBAHA.112.300128 ↗
47. The role of amino acids in hydroxyapatite mineralization10.1098/rsif.2016.0462 ↗
48. Localization of Phosphorylated Serine, Osteopontin, and Bone Sialoprotein on Bone Fracture Surfaces10.1080/00218460902996424 ↗
49. Merolli, A., and Santin, M. (2009). Role of Phosphatidyl-Serine in Bone Repair and Its Technological Exploitation. Molecules, 14.10.3390/molecules14125367 ↗
50. Inhibition of apatite crystal growth by the amino-terminal segment of human salivary acidic proline-rich proteins10.1007/BF02405385 ↗
51. Acquired Enamel Pellicle Engineered Peptides: Effects on Hydroxyapatite Crystal Growth10.1038/s41598-018-21854-4 ↗
52. Dependence of the Interfacial Behavior of β-Casein on Phosphoserine Residues10.3168/jds.S0022-0302(03)73995-2 ↗
53. Experimental evidence for previously unclassified calcium phosphate structures in the casein micelle10.3168/jds.2017-12623 ↗
54. Adsorption of O-Phospho-L-Serine and L-Serine onto Poorly Crystalline Apatite10.1006/jcis.2001.7450 ↗
55. Formation of Hydroxyapatite in the Presence of Phosphorylated Polyvinylalcohol as a Simplified Model Compound for Mineralization Regulator Phosphoproteins10.1248/cpb.38.1810 ↗
56. Effects of Full-Length Phosphorylated Osteopontin and Constituent Acidic Peptides and Amino Acids on Calcite Dissolution10.1021/cg4012394 ↗
57. Salivary statherin. Dependence on sequence, charge, hydrogen bonding potency, and helical conformation for adsorption to hydroxyapatite and inhibition of mineralization10.1016/S0021-9258(18)42650-6 ↗
58. Kinetics of dissolution of calcium hydroxyapatite: IV. The effect of some biologically important inhibitors10.1016/0022-0248(81)90054-3 ↗
59. Incongruent dissolution of hydroxyapatite in the presence of phosphoserine10.1007/BF00660306 ↗
60. Pujari-Palmer, M., Guo, H., Wenner, D., Autefage, H., Spicer, D.C., Stevens, M.M., Omar, O., Thomsen, P., Edén, M., and Insley, G. (2018). A Novel Class of Injectable Bioceramics That Glue Tissues and Biomaterials. Materials, 11.10.3390/ma11122492 ↗
61. Bioinspired Mineral-Organic Bioresorbable Bone Adhesive10.1002/adhm.201800467 ↗
62. Procter, P., Pujari-Palmer, M., Hulsart-Billström, G., Wenner, D., Insley, G., Larsson, S., and Engqvist, H. (2019). A biomechanical test model for evaluating osseous and osteochondral tissue adhesives. BMC Biomed. Eng., 1.10.1186/s42490-019-0011-2 ↗
63. Liu, X., Pujari-Palmer, M., Wenner, D., Procter, P., Insley, G., and Engqvist, H. (2019). Adhesive Cements That Bond Soft Tissue Ex Vivo. Materials, 12.10.3390/ma12152473 ↗
64. Is there a relationship between solubility and resorbability of different calcium phosphate phases in vitro?10.1016/j.bbagen.2016.05.022 ↗
65. Interlaboratory studies on in vitro test methods for estimating in vivo resorption of calcium phosphate ceramics10.1016/j.actbio.2015.07.040 ↗
66. Microelectrode studies on the acid microenvironment beneath adherent macrophages and osteoclasts10.1016/0014-4827(88)90191-7 ↗
67. Static and Dynamic Degradation of Sintered Calcium Phosphate Ceramics
68. Procter, P., Pujari-Palmer, M., Insley, G., and Engqvist, H. (2017). Composition of Alfa-Tcp, Silicate and Phosphorylated Amino Acid. (Application EP2017074551), European Patent.
69. Procter, P., Pujari-Palmer, M., Insley, G., and Engqvist, H. (2017). Soft Tissue Adhesive Composition of Alfa-Tcp and Phosphorylated Amino Acid. (Application EP2017074553), European Patent.
70. Procter, P., Pujari-Palmer, M., Insley, G., and Engqvist, H. (2018). Composition of a Calcium Phosphate and an Additive Compound Containing a Phosphate or Phosphonate Group. (Application PCT/EP2018/083197), European Patent.
71. Kinetics of dissolution of calcium phosphate (Ca-P) bioceramics10.2298/PAC0801057B ↗
72. Comparative study on the resorbability and dissolution behavior of octacalcium phosphate, β-tricalcium phosphate, and hydroxyapatite under physiological conditions10.4012/dmj.2015-255 ↗
73. Long-Term In Vitro Degradation of a High-Strength Brushite Cement in Water, PBS, and Serum Solution10.1155/2015/575079 ↗
74. Theoretical analysis of calcium phosphate precipitation in simulated body fluid10.1016/j.biomaterials.2004.05.034 ↗
75. Sugiura, Y., and Ishikawa, K. (2018). Effect of Calcium and Phosphate on Compositional Conversion from Dicalcium Hydrogen Phosphate Dihydrate Blocks to Octacalcium Phosphate Blocks. Crystals, 8.10.3390/cryst8050222 ↗
76. Calcium Phosphate Solubility: The Need for Re-Evaluation10.1021/cg801118v ↗
77. Degradable biocomposite of nano calcium-deficient hydroxyapatite-multi(amino acid) copolymer10.2147/IJN.S28978 ↗
78. Apatite Formation: Why It May Not Work as Planned, and How to Conclusively Identify Apatite Compounds10.1155/2013/490946 ↗
79. Amorphous calcium phosphate materials: Formation, structure and thermal behaviour10.1016/j.jeurceramsoc.2018.11.003 ↗
80. Effect of amino acid on calcium phosphate phase transformation: Attenuated total reflectance-infrared spectroscopy and chemometrics10.1007/s00396-018-4438-0 ↗
81. Berzina-Cimdina, L., and Borodajenko, N. (2015). Research of Calcium Phosphates Using Fourier Transform Infrared Spectroscopy, Infrared Spectroscopy, IntechOpen.
82. The role of prenucleation clusters in surface-induced calcium phosphate crystallization10.1038/nmat2900 ↗
83. Effect of carbonate content and buffer type on calcium phosphate formation in SBF solutions10.1007/s10856-006-9680-1 ↗
84. The role of amorphous phase in nucleating bone-like apatite on plasma-sprayed hydroxyapatite coatings in simulated body fluid10.1023/A:1018529924527 ↗
85. Influence of Ca/P ratios of starting solutions on the crystallization of amorphous calcium phosphate to hydroxyapatite10.1007/BF03027322 ↗
86. Bone adhesives for trauma surgery: A review of challenges and developments10.1016/j.ijadhadh.2011.11.009 ↗
87. (2017). Implants for Surgery—In Vitro Evaluation for Apatite-Forming Ability of Implant Materials, ISO. International Organization for Standards (ISO) 23317:2007.
88. (2014). Implants for Surgery—In Vitro Evaluation of Apatite-Forming Ability of Implant Materials, ISO. International Organization for Standards (ISO) 23317:2014.
89. Can bioactivity be tested in vitro with SBF solution?10.1016/j.biomaterials.2009.01.008 ↗
90. Influence of cement compressive strength and porosity on augmentation performance in a model of orthopedic screw pull-out10.1016/j.jmbbm.2017.10.016 ↗
91. Development and Characterization of Biphasic Hydroxyapatite/β-TCP Cements10.1111/jace.12861 ↗
92. (2012). Biological evaluation of medical devices. Part 12: Sample Preparation and Reference Materials, ISO. International organization for standards (ISO) 10993-12:2012.
93. (2001). Biological evaluation of medical devices. Part 14: Identification and Quantification of Degradation Products from Ceramics, ISO. International organization for standards (ISO) 10993-13:2001.
94. A mathematical model of osteoclast acidification during bone resorption10.1016/j.bone.2016.09.007 ↗